HIGHFDA DEVICE

BD Kiestra ReadA Lab Automation Module Recalled in 2026 Over Connectivity Delays (82 Units)

BD Kiestra recalled 82 units of its ReadA lab automation module on February 6, 2026, including 7 in the United States and 65 overseas. The issue arises after a system reboot when one or more modules become unreachable via the remote connectivity interface, potentially delaying plate retrieval from the incubator. The problem is intermittent and did not affect test results, assay performance, or var

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
February 6, 2026
Status
ACTIVE
Severity
6/10

Quick Facts at a Glance

Recall Date
February 6, 2026
Hazard Level
HIGH
Brand
BD Kiestra Lab Automation
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
6 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
BD Kiestra Lab Automation
Product type
Laboratory automation module
Model numbers
446948, 00382904469481
Sold at
Multiple Retailers
Where affected
KS, MD, MN, NJ, TX, VA

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    February 6, 2026

  2. Reported by FDA DEVICE

    April 8, 2026

  3. RecallRadar source check

    April 15, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

In certain situations, following a system reboot, one or more modules may have become unreachable via the remote connectivity interface. When this occurred, there was potential for delays in plate retrieval from the incubator while connectivity was restored. This issue was intermittent and did not affect test results, performance of the assay, or sample integrity.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact BD KIESTRA LAB AUTOMATION or your healthcare provider for instructions. Notification method: Letter

About This Product

BD Kiestra ReadA is part of the BD Kiestra Lab Automation system used in clinical microbiology labs to automate plate incubation and processing.

Why This Is Dangerous

An intermittent connectivity issue after reboot can render modules unreachable via the remote interface, causing delays in plate retrieval from the incubator. The issue has not affected test results, assay performance, or sample integrity.

Industry Context

This recall is not described as part of a broader industry pattern.

Real-World Impact

Delays in plate retrieval may affect workflow and turnaround times in busy labs. There is no reported impact on test accuracy or sample integrity.

Practical Guidance

How to identify if yours is affected

  1. Check Catalog No. 446948 on the device label.
  2. Confirm Serial Numbers: All.
  3. Review recall notice and determine if the unit matches the affected characteristics.

Where to find product info

On the device label, recall notification, and FDA recall page linked to the notice.

What timeline to expect

Not specified by the manufacturer.

If the manufacturer is unresponsive

  • Escalate to hospital risk management
  • Document all interactions with the vendor
  • Consider regulatory reporting if delays impact patient safety

How to prevent similar issues

  • Ensure software updates and connectivity integrity for lab automation modules
  • Develop backup workflows for plate retrieval during outages
  • Verify device compatibility before integrating new modules

Documentation advice

Keep the recall notification, device identifiers, distribution records, and all correspondence with the manufacturer for audit trails.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Catalog No.: 446948; UDI-DI: 00382904469481; Serial Numbers: All; Quantity: 82 units (7 US, 65 OUS); Domestic distribution: KS, MD, MN, NJ, TX, VA; International distribution: Australia, Austria, Belgium, Canada, China, Denmark, France, Germany, Hong Kong, Italy, Kuwait, Mexico, Morocco, Netherlands, Norway, Saudi Arabia, Spain, Sweden, Switzerland, Taiwan, United Kingdom; Recall date: 2026-02-06; Company: BD Kiestra Lab Automation; Status: ACTIVE.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 82 units recalled (7 US, 65 OUS)
  • Serial Numbers: All
  • Domestic distribution: KS, MD, MN, NJ, TX, VA
  • International distribution: Australia, Austria, Belgium, Canada, China, Denmark, France, Germany, HK

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
6/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product TypeLaboratory automation module
Sold At
Multiple Retailers

Product Details

Model Numbers
446948
00382904469481
Affected States
KS, MD, MN, NJ, TX, VA
Report Date
April 8, 2026
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more